Tag Archives: Gilead’s

FDA approves Gilead’s remdesivir as coronavirus treatment

The Food and Drug Administration on Thursday approved Gilead Sciences‘ antiviral drug remdesivir as a treatment for the coronavirus. In May, the FDA granted the drug an emergency use authorization, allowing hospitals and doctors to use the drug on patients hospitalized with the disease even though the drug has not been formally approved by the… Read More »

U.S. emergency approval broadens use of Gilead’s COVID-19 drug remdesivir

WASHINGTON (Reuters) – Gilead Science Inc’s (GILD.O) antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States. During a meeting in the Oval Office of the White House with President… Read More »